- Home
- RVPHW vs L Comparison
RVPHW vs L Comparison
Compare RVPHW & L Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- L
- Stock Information
- Founded
- RVPHW 2018
- L 1969
- Country
- RVPHW United States
- L United States
- Employees
- RVPHW 14
- L N/A
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- L Property-Casualty Insurers
- Sector
- RVPHW Health Care
- L Finance
- Exchange
- RVPHW Nasdaq
- L Nasdaq
- Market Cap
- RVPHW N/A
- L 18.5B
- IPO Year
- RVPHW N/A
- L N/A
- Fundamental
- Price
- RVPHW $0.03
- L $91.61
- Analyst Decision
- RVPHW
- L
- Analyst Count
- RVPHW 0
- L 0
- Target Price
- RVPHW N/A
- L N/A
- AVG Volume (30 Days)
- RVPHW 22.4K
- L 875.8K
- Earning Date
- RVPHW 03-14-2025
- L 07-28-2025
- Dividend Yield
- RVPHW N/A
- L 0.27%
- EPS Growth
- RVPHW N/A
- L N/A
- EPS
- RVPHW N/A
- L 6.09
- Revenue
- RVPHW N/A
- L $17,773,000,000.00
- Revenue This Year
- RVPHW N/A
- L N/A
- Revenue Next Year
- RVPHW N/A
- L N/A
- P/E Ratio
- RVPHW N/A
- L $14.85
- Revenue Growth
- RVPHW N/A
- L 8.71
- 52 Week Low
- RVPHW $0.13
- L $73.15
- 52 Week High
- RVPHW $0.15
- L $92.42
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- L 60.09
- Support Level
- RVPHW N/A
- L $88.76
- Resistance Level
- RVPHW N/A
- L $90.90
- Average True Range (ATR)
- RVPHW 0.00
- L 1.07
- MACD
- RVPHW 0.00
- L 0.14
- Stochastic Oscillator
- RVPHW 0.00
- L 96.63
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About L Loews Corporation
Loews Corp is a holding company along with its subsidiary engaged in commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, operation of a chain of hotels, and also in the manufacture of rigid plastic packaging solutions. It has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA Financial Corporation, Boardwalk Pipeline Partners, LP and Loews Hotels Holding Corporation; and the Corporate segment.